Vital Strategies: New Michigan Report Identifies Under-Prescribing of Treatment for Opioid Use Disorder
June 10, 2022
June 10, 2022
NEW YORK, June 10 (TNSres) -- Vital Strategies issued the following news release:
A new report from the Michigan Department of Licensing and Regulatory Affairs and Vital Strategies suggests that the buprenorphine treatment gap for people with opioid use disorder is partially reinforced by practitioners prescribing below their authorized patient capacities. The findings of this report come amidst an intensifying overdose crisis that claimed over 100,000 lives last year.
. . .
A new report from the Michigan Department of Licensing and Regulatory Affairs and Vital Strategies suggests that the buprenorphine treatment gap for people with opioid use disorder is partially reinforced by practitioners prescribing below their authorized patient capacities. The findings of this report come amidst an intensifying overdose crisis that claimed over 100,000 lives last year.
. . .